TX 75083-3836, U.S.A., fax 01-972-952-9435.
AbstractHydrates remain a significant flow assurance issue in nearly every Deepwater development. Traditional hydrate control methods of insulation and/or thermodynamic chemical inhibition may not provide the desired level of hydrate protection at an economic price. Low-Dosage Hydrate Inhibitors (LDHIs) are a proven technology to control hydrates in numerous applications and are instrumental in reducing the total cost of operations (TCO). In particular, LDHIs offer solutions to existing problems such as unexpected water breakthrough, undersized methanol injection capacity, and high-volume methanol transportation / storage limitations. As an added benefit, it is possible to co-formulate LDHIs with other production chemicals, such as paraffin and corrosion inhibitors, and thus minimize the number of chemical injection lines. While the benefits to existing developments are appreciable, the true potential of this technology lies in the reduced capital expenditures (Cap Ex) required for systems designed specifically for LDHIs. Potential savings include, smaller umbilical line diameters, the elimination of a methanol wash and recovery operation, fewer umbilical lines, smaller / lighter storage capacity, and smaller pumps.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.